Explaining STIMO

Roundtable conversation with Grégoire Courtine, the International Paraplegic Foundation chair in spinal cord repair at the Center for Neuroprosthetics and the Brain Mind Institute at the Swiss Federal Institute of Technology in Lausanne; Jocelyne Bloch, a neurosurgeon at Lausanne University Hospital; and ONWARD CEO David Marver as they discuss the findings from the new study STIMO published in Nature Medicine.

Linda Schultz, Ph.D., CRRN, a leader and provider of rehabilitation nursing for over 30 years moderated this discussion about the clinical trial results and what this means for the SCI community and the future of epidural stimulation research.

The Christopher & Dana Reeve Foundation is an equity partner of ONWARD, a Netherlands-based company that has developed breakthrough technology currently in global clinical trials that deliver targeted, programmed stimulation of the spinal cord to restore movement and other functions.

Recorded February 17, 2022.